Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia

Psychological Medicine - Tập 23 Số 4 - Trang 925-940 - 1993
Heinz Häfner1, Anita Riecher‐Rössler1, Wolfram an der Heiden1, Kathrin Maurer1, B. Fätkenheuer1, W. Löffler1
1Schizophrenia Research Unit, Central Institute of Mental Health, Mannheim, Germany

Tóm tắt

SynopsisMotivated by the lack of knowledge of the pathophysiological processes underlying the manifestation of symptoms in schizophrenia, we have worked out a systematic search strategy. Since epidemiological distribution patterns consistently deviating from expected values provide valuable indications of causal relationships, we chose the higher age of females at first admission for schizophrenia, first reported by Kraepelin and since then confirmed in over 50 studies, as the basis for our study. This unexplained epidemiological finding was replicated on Danish and Mannheim case-register data by systematically controlling for selection and diagnostic artefacts and by testing alternative explanations at the individual stage of the study. To check whether the difference in age at first admission was determined by a difference in age at onset, a representative sample of 267 first-admitted patients with non-affective functional psychosis was examined by using an interview for the retrospective assessment of the onset of schizophrenia (IRAOS) designed for this purpose. Any of the definitions of first-ever onset applied – first sign of mental disorder, first psychotic symptom, first acute episode – led to a significant age difference of 3·2 to 4·1 years between the sexes. The distribution of onsets across the life cycle showed a later increase and a second, lower peak between the ages of 45 and 54 years among females compared with males. The lifetime risk for schizophrenia was equal for males and females. After testing the plausibility of psychosocial versus biological explanations we hypothesized that due to the effect of oestrogens the vulnerability threshold for schizophrenia is elevated in females until the menopause. Animal experiments and post mortem analyses showed that chronic oestrogen applications significantly shortened dopamine-induced behaviour and reduced D2 receptor sensitivity in the brain. The applicability of this pathophysiological mechanism to human schizophrenia was tested on acutely schizophrenic females with normal menstrual cycles. A significant negative correlation was found between measures of symptomatology and plasma oestrogen levels. The manifestation of symptoms in schizophrenia appears to be influenced by a sufficiently sensitive D2 receptor system in the brain, blocked by neuroleptics and modulated by oestrogens.

Từ khóa


Tài liệu tham khảo

10.1192/bjp.162.1.80

Weyerer, 1984, Prävalenz und Behandlung psychischer Erkrankungen in der Allgemeinbevölkerung. Ergebnisse einer Feldstudie in drei Gemeinden Oberbayerns, Nervenarzt, 55, 30

Lewine, 1988, Handbook of Schizophrenia, 3, 379

Lindelius, 1970, A study of schizophrenia, Acta Psychiatrica Scandinavica Supplementum, 216

Häfner H. & Maurer K. (1992). The methodology of first onset assessment by the example of schizophrenia.Paper presented at the Meeting on First Onset of Affective Disorders of the John D. and Catherine T. MacArthur Foundation Research Network inFrankfurt, 6 April, 1992.

10.1007/978-3-642-71765-9_6

Weyerer S. (1991). Social risk factors in schizophrenia.Paper presented at the WPA Congress ‘Changing psychiatry in changing societies’,Budapest (Hungary), August 23–25, 1991.

Hollander, 1973, Nonparametric Statistical Methods

10.1093/schbul/16.2.185

10.1192/bjp.92.386.35

10.1007/978-3-642-87688-2

Biehl, 1989, The WHO Psychological Impairments Rating Schedule (WHO/PIRS). I. Introducing a new instrument for rating observed behaviour and the rationale of the psychological impairment concept, British Journal of Psychiatry, 155, 68, 10.1192/S0007125000291538

Stevens, 1969, Marriage and Fertility of Women Suffering from Schizophrenia or Affective Disorders. Maudsley Monograph No. 19

10.1017/S0033291700005626

10.2307/350723

10.1192/bjp.152.6.793

10.1111/j.1600-0447.1986.tb02738.x

Kraepelin, 1909, Psychiatrie, 1–4

10.1016/0920-9964(92)90004-O

Bleuler, 1943, Die spätschizophrenen Krankheitsbilder, Neurologie, XV/9, 259

10.1093/schbul/8.3.470

10.1017/S0021932000008488

10.1126/science.1546291

Dunham, 1965, Community and Schizophrenia: An Epidemiological Analysis

10.1111/j.1600-0447.1975.tb00048.x

Fätkenheuer B. , Riecher-Rössler A. , Löffler W. & Häfner H. (1992). Social biography in schizophrenic patients.Poster presented at the AEP Section Committee Meeting in Zürich,8–10 April, 1992.

Häfner, 1971, Der Einfluss von Umweltfaktoren auf das Erkrankungsrisiko für Schizophrenie, Nervenarzt, 42, 557

10.1007/978-3-642-71765-9

Häfner, 1991, Warum erkranken Frauen später an Schizophrenie? Erhöhung der Vulnerabilitätsschwelle durch Östrogen, Nervenheilkunde, 10, 154

10.1016/0165-1781(91)90038-Q

Hambrecht, 1992, Transnational stability of gender differences in schizophrenia?, An analysis based on the WHO Study on Determinants of Outcome of Severe Mental Disorders. European Archives of Psychiatry and Clinical Neuroscience, 242, 6

Helgason, 1964, Epidemiology of mental disorders in Iceland, Acta Psychiatrica Scandinavica Supplementum, 173

Henn, 1987, Psychopharmacology: The Third Generation of Progress, 687

10.2466/pr0.1966.19.1.180

10.1093/schbul/12.1.52

Jablensky, 1992, Schizophrenia: Manifestations, Incidence and Course in Different Cultures. A World Health Organization Ten-Country Study. Psychological Medicine Monograph Supplement 20

Jenkins, 1968, Spectral Analysis and Its Applications

Kretschmer, 1921, Körperbau und Charakter. Untersuchungen zum Konstitutionsproblem und zur Lehre von den Temperamenten

Link, 1980, Mental Illness in the United States: Epidemiologic Estimates, 133

10.1001/archpsyc.1984.01790130053007

10.1177/070674378202700204

10.1177/014107688708000313

10.2466/pr0.1962.10.3.799

Riecher-Rössler A. , Häfner H. , Stummbaum M. , Maurer K. & Schmidt R. (1993). Can estradiol modulate schizophrenic symptomatology? Schizophrenia Bulletin (in the press).

10.1093/sf/58.2.540

Salokangas, 1987, Reports of Psychiatria Fennica, No. 78: Skitsofreninan Tutkimuksen, Hoidon ja Kuntoutuksen Valtakunnallinen Kehittämisohjelma

10.1017/S0033291700011910

Schneider, 1950, Klinische Psychopathologie

Shepherd, 1989, The Natural History of Schizophrenia: A Five-year Follow-up Study of Schizophrenics. Psychological Medicine Monograph Supplement 15

1990, Statistisches Jahrbuch 1990 für die Bundesrepublik Deutschland

10.1007/BF02865780

10.1097/00005053-198701000-00006

10.1093/schbul/12.2.173

Wing, 1974, Measurement and Classification of Psychiatric Symptoms: An Instruction Manual for PSE and CATEGO Program

1973, The International Pilot Study of Schizophrenia, 1, 73

1978, Psychiatric and personal History Schedule

1988, Psychiatric Disability Assessment Schedule

Zerssen, 1976, Klinische Selbstbeurteilungs-Skalen (KSb-S) aus dem Münchner Psychiatrischen Informationssystem (PSYCHIS München)

10.1192/bjp.99.417.778

Harrer S. (1987). Über das Zusammenwirken von Östradiol und Dopamin bei der Verhaltenssteuerung von Säugern. Doctoral thesis. Biologisches Institute der Universität Stuttgart.

10.1007/BF02191557

Iacono, 1989, The Emergence of a Discipline, I, 221

10.1007/BF00380979

10.1001/archpsyc.1982.04290070020005

10.1007/BF00377422

10.1037/0021-843X.94.1.42

Murray, 1990, Is schizophrenia disappearing?, Lancet, 335, 513, 10.1016/0140-6736(90)90745-Q

Löffler W. , Fätkenheuer B. , Maurer K. , Riecher-Rössler A. , Lützhøft J. , Skadhede S. , Munk-Jørgensen P. , Strömgren E. & Häfner H. (1993). Validation of Danish case-register diagnosis – schizophrenia – ICD-295. Acta Psychiatrica Scandinavica (in the press).

10.1016/0920-9964(92)90109-I

10.1007/978-3-642-76841-5_10

Thông tin
Thông tin xuất bản

Psychological Medicine

Tập 23 Số 4

925-940

Thông tin tác giả